RenoVate Therapeutics Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesBiotechnology
Core Technology
BiologicalsCells
Tags (4)
biotechnologynephrologydialysispharmaceuticals
RenoVate Therapeutics Financials
Undisclosed
Capital raised
Cumulative Funding Raised Over Time ($)
RenoVate Therapeutics Lifecycle
Cumulative Funding Raised Over Time
RenoVate Therapeutics News
0 articles
No news articles.
RenoVate Therapeutics Team
Benjamin Dekel
Founder & Chief Scientist
Founder
Daniel Clayman
Co-founder
Founder
Employee Info
| Employees (range) | 1-10 |
| Exact count | 7 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.